Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]

New immunotherapy yields long-lasting responses in some patients with advanced...

Dr Mark Middleton - University of Oxford, Oxford, UK

New immunotherapy yields long-lasting responses in some patients with advanced melanoma ( Dr Mark Middleton - University of Oxford, Oxford, UK )

Incidences of liver cancer rising in the USA

Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA

Incidences of liver cancer rising in the USA ( Dr Anna Mae Diehl - Duke University Medical Center, Durham, USA )

What are the objectives for CART-meso immunotherapy?

Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA

What are the objectives for CART-meso immunotherapy? ( Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA )

New data shows that generic drivers are found in benign conditions

Prof Razelle Kurzrock - University of California, San Diego, USA

New data shows that generic drivers are found in benign conditions ( Prof Razelle Kurzrock - University of California, San Diego, USA )

How will genomics be applied to patient therapy in future?

Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas

How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )

New T cell–based immunotherapy shows promise for lethal stem cell transplant...

Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )

ecancermedicalscience editor's choice for April 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for April 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Positive results in phase II study of copanlisib treating NHL and CLL

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust...

Positive results in phase II study of copanlisib treating NHL and CLL ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )

Dual mTOR inhibition effective in reducing tumour load in CLL

Dr Emilio Cosimo - University of Glasgow, Glasgow, UK

Dual mTOR inhibition effective in reducing tumour load in CLL ( Dr Emilio Cosimo - University of Glasgow, Glasgow, UK )

Putting the patient at the centre of cancer-associated thrombosis treatment...

Dr Simon Noble - Cardiff University, Cardiff, UK

Putting the patient at the centre of cancer-associated thrombosis treatment decisions ( Dr Simon Noble - Cardiff University, Cardiff, UK )

Inside cancer - public lecture

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

Inside cancer - public lecture ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Pembrolizumab showed clinical benefit in malignant pleural mesothelioma

Dr Evan Alley - University of Pennsylvania, Philadelphia, USA

Pembrolizumab showed clinical benefit in malignant pleural mesothelioma ( Dr Evan Alley - University of Pennsylvania, Philadelphia, USA )

More from ecancer